A detailed history of Camelot Portfolios, LLC transactions in Sensus Healthcare, Inc. stock. As of the latest transaction made, Camelot Portfolios, LLC holds 53 shares of SRTS stock, worth $348. This represents 0.0% of its overall portfolio holdings.

Number of Shares
53
Holding current value
$348
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$3.14 - $6.42 $166 - $340
53 New
53 $0

Others Institutions Holding SRTS

About Sensus Healthcare, Inc.


  • Ticker SRTS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 16,556,000
  • Market Cap $109M
  • Description
  • Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy (SRT), a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provide...
More about SRTS
Track This Portfolio

Track Camelot Portfolios, LLC Portfolio

Follow Camelot Portfolios, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Camelot Portfolios, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Camelot Portfolios, LLC with notifications on news.